Showing 1,459 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Access to healthcare

Petition: Equitable access to HCV drugs

Editor's pick
Petitionbuzz
30 January 2015
New & experimental HIV treatments

PREZCOBIX™ (darunavir/cobicistat) approved in the U.S. for the treatment of adults living with HIV-1

Editor's pick
Janssen press release
30 January 2015
New & experimental HIV treatments

U.S. Food and Drug Administration approves Bristol-Myers Squibb’s Evotaz™ (atazanavir and cobicistat) for the treatment of HIV-1 infection in adults

Editor's pick
Bristol-Myers Squibb press release
30 January 2015
Transmission & prevention

European Advocates Engage with Biomedical Prevention

Editor's pick
AVAC
28 January 2015
Access to healthcare

MSF response to Gilead announcement on inclusion of hepatitis C drug GS-5816 in voluntary licence

Editor's pick
Médecins Sans Frontières press release
27 January 2015
New & experimental hepatitis C treatment

Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent

Editor's pick
Gilead press release
27 January 2015
Pharmaceutical industry

Merck (MRK) Receives Positive CHMP Opinion for Dutrebis as HIV 1 Treatment

Editor's pick
Street Insider
26 January 2015
Access to healthcare

Ahead of Obama visit, MSF warns US pressure on India could impact access to medicines for millions

Editor's pick
Medecins Sans Frontieres press release
23 January 2015
Activism & civil society

Peru: Patients Demand End to Monopoly on HIV Medication

Editor's pick
TeleSUR
21 January 2015
Hepatitis C treatment

Gilead and AbbVie take hepatitis C battle to Europe

Editor's pick
Financial Times (free registration required)
20 January 2015
Access to healthcare

How India's Patent Office Destroyed Gilead's Global Game Plan

Editor's pick
Bloomberg Businessweek
19 January 2015
Hepatitis C treatment

The Cynical Connectedness of Gilead's Hepatitis C Pricing and Anti-Diversion Policies

Editor's pick
The Body Pro
19 January 2015
Hepatitis C treatment

How Much Could AbbVie Inc. Make Selling Its Hepatitis C Drug This Year?

Editor's pick
The Motley Fool
15 January 2015
Hepatitis C treatment

India rejects Gilead's Hepatitis C drug patent request

Editor's pick
Reuters
14 January 2015
Hepatitis C treatment

US: Prime Therapeutics breaks from competition, strikes deals to prefer both Harvoni, Viekira hepatitis C drugs

Editor's pick
Prime Therapeutics press release
13 January 2015
New & experimental hepatitis C treatment

Merck speeds up drug-submission plans for hep C, lung cancer

Editor's pick
Reuters
13 January 2015
Finance & funding

South Africa secures 'world's lowest prices' for HIV drugs

Editor's pick
Business Day
7 January 2015
Pharmaceutical industry

Gilead, Janssen Expand HIV Combo Collaborations

Editor's pick
Genetic Engineering & Biotechnology News
30 December 2014
Pharmaceutical industry

Gilead Sciences, Inc. Can't Do It Alone

Editor's pick
Motley Fool
30 December 2014
Health services & systems

US: Consumer Group Sues Aetna, Claiming Discrimination Against HIV Patients

Editor's pick
New York Times
26 December 2014
Hepatitis C treatment

Even with New AbbVie Drug, Many Hepatitis C Patients Are Being Turned Away from Treatment

Editor's pick
Hepatitis C News
23 December 2014
Hepatitis C treatment

Gilead slides after hepatitis drug setback

Editor's pick
Financial Times (free registration required)
23 December 2014
Drug-resistant TB

Johnson & Johnson announces collaboration between Janssen and USAID to expand access to anti-multidrug-resistant tuberculosis (MDR-TB) compound

Editor's pick
PR Newswire
12 December 2014
Pharmaceutical industry

Class Action Lawsuit Challenges Exorbitant Pricing of Gilead’s Hepatitis-C Drug Sovaldi

Editor's pick
Chimicles & Tikellis press release
12 December 2014